These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6454388)

  • 1. In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics.
    Kuck NA; Testa RT; Forbes M
    Antimicrob Agents Chemother; 1981 Apr; 19(4):634-8. PubMed ID: 6454388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azlocillin and mezlocillin: new ureido penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of furazlocillin (Bay k 4999) compared with those of mezlocillin, piperacillin, and standard beta-lactam antibiotics.
    Gootz TD; Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):783-91. PubMed ID: 475364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of mezlocillin against community hospital isolates in comparison to other penicillins and cephalosporins.
    Parry MF; Folta D
    J Antimicrob Chemother; 1983 May; 11 Suppl C():97-102. PubMed ID: 6619043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the in vitro activity of Bay k 4999 and piperacillin, two new antipseudomonal broad-spectrum penicillins, with other beta-lactam drugs.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Oct; 14(4):549-52. PubMed ID: 102245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
    Marklein G; Häfelein J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):40-53. PubMed ID: 6277101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi.
    Robinson RG; Saunders J; Cassel R; Block CS; Koornhof HJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):493-501. PubMed ID: 6449903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
    Moody JA; Peterson LR; Gerding DN
    Antimicrob Agents Chemother; 1984 Aug; 26(2):256-9. PubMed ID: 6435516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli.
    Delgado DG; Brau CJ; Cobbs CG; Dismukes WE
    Antimicrob Agents Chemother; 1979 Dec; 16(6):864-8. PubMed ID: 533267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin.
    Chattopadhyay B; Hall I; Curnow SR
    Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.